AA

Akshay Anand

Active Director Director DIN 07490801
DIN 07490801 First appointment May 2016 Primary industry Transport and Logistics
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since May 2016
Shareholding value •••• Premium profile

About Akshay Anand

Data last updated:

Akshay Anand is a Director at Navigato Private Limited (since 2019), Director at Essences Studio Private Limited (since 2022) and Director at Trombone Pharma Private Limited (since 2024), and holds 3 more current directorships. The companies operate in Transport and Logistics, Media and Publishing and Trading. The 3 current companies with reported revenue have a combined latest revenue of ₹2.88 Cr; the largest is Navigato Private Limited at ₹2.07 Cr (FY 2023). Earlier, Akshay Anand was a Director at Retnec Solutions Private Limited (from 2016).

DIN 07490801
Primary Designation Director
Industry Transport and Logistics
First Appointment 20 May 2016
Oldest Company Age 10 yrs
Largest company Navigato Private Limited · ₹2.07 Cr (FY 2023)
Combined revenue ₹2.88 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Navigato Private Limited U74110HR2019PTC078295
Director04 Feb 20192019₹2.07 Cr (FY 2023)Active
Essences Studio Private Limited U72900HR2020PTC091444
Director02 Nov 20222020₹52 Lakh (FY 2024)Active
Trombone Pharma Private Limited U51909KA2020PTC138351
Director09 Mar 20242020₹29.1 Lakh (FY 2025)Active
Rvedic Private Limited U46497HR2025PTC135478
Director26 Aug 20252025Active
Director15 Oct 20242024Active
Artarium Llp ABA-8854
Designated Partner12 Apr 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Retnec Solutions Private Limited U72900HR2016PTC064188
Director20 May 20162016Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Retnec Solutions Private Limited
Essences Studio Private Limited
Navigato Private Limited
Artarium Llp
Premium access

Shareholding and investment profile for Akshay Anand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshay Anand

Akshay Anand currently holds 6 directorships: Navigato Private Limited (Director, since 04 Feb 2019, revenue ₹2.07 Cr (FY 2023)); Essences Studio Private Limited (Director, since 02 Nov 2022, revenue ₹52 Lakh (FY 2024)); Trombone Pharma Private Limited (Director, since 09 Mar 2024, revenue ₹29.1 Lakh (FY 2025)); Rvedic Private Limited (Director, since 26 Aug 2025); Heliootropic Developers Private Limited (Director, since 15 Oct 2024); and 1 more.

Akshay Anand was first appointed on 20 May 2016 as Director at Retnec Solutions Private Limited. The most recent appointment on record is 26 Aug 2025 at Rvedic Private Limited.

The 3 current companies of Akshay Anand that report revenue have a combined latest revenue of ₹2.88 Cr: Navigato Private Limited ₹2.07 Cr (FY 2023); Essences Studio Private Limited ₹52 Lakh (FY 2024); Trombone Pharma Private Limited ₹29.1 Lakh (FY 2025).

Akshay Anand held 1 earlier board appointment: Retnec Solutions Private Limited (Director, from 20 May 2016).

The current boards of Akshay Anand's companies include Dhruv Pratap Singh (Navigato Private Limited), Pavnendra Bhadauria (Navigato Private Limited), Laxmi Sharma (Trombone Pharma Private Limited), Uddeshya Sharma (Trombone Pharma Private Limited), Shivendra Bahaduriya (Heliootropic Developers Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available